Keyword: diabetes treatment
News
07.06.2013
- In a leafy suburb of Frankfurt, a state-of-the-art plant churns out up to 1 million insulin pens every day in French drugmaker Sanofi's drive to keep its no. 2 spot in the $43...
News
07.06.2013
- U.S. health advisers voted on Thursday to recommend relaxing market restrictions on GlaxoSmithKline's diabetes drug Avandia, the former blockbuster at the center of one of the...
News
03.05.2013
- Eli Lilly, the world's fourth-largest diabetes drugs maker, aims to have the widest range of anti diabetic drugs in order to win a larger slice in the growing market. The global...
News
02.05.2013
- Sanofi is stepping up the development of a fixed combination of diabetes treatments Lantus and Lyxumia to sidestep an earlier setback with a similar pen device and take advantage...
News
01.05.2013
- Denmark's Novo Nordisk could see the U.S. launch of its biggest drug hope, a new long-acting insulin, delayed until 2018 while it conducts more tests to satisfy regulators, it said...
News
31.01.2013
- The world's biggest insulin producer Novo Nordisk raised sales and profit forecasts for 2013 on hopes its new Tresiba drug will soon win approval in the United States and add...
News
19.12.2012
- Swiss drugmaker Roche would still consider buying a gene-sequencing company to fit its strategy of tailoring treatments to specific patients, after dropping a $6.8 billion bid for...
News
07.12.2012
- Bayer is unlikely to sell its blood glucose meters business for the time being, after failing to generate sufficient interest from buyers, two people familiar with the situation...
